GoodRx Holdings Overview
GoodRx Holdings Target Price
Analysts' 12-month price predictions for GDRX.
Share Price
$4.48
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-06-10 | Morgan StanleyCraig Hettenbach | $9.5 |  112.1% upside |  |
| 2024-05-23 | RBC CapitalMark Mahaney | $10 | 123.2% upside | |
| 2024-05-16 | BarclaysStephanie Davis | $9 | 100.9% upside | |
| 2024-05-16 | Raymond JamesAaron Kessler | $10 | 123.2% upside | |
| 2024-04-10 | BOCOM International Holdings CompanyScott Schoenhaus | $9 | 100.9% upside | |
| 2024-04-10 | KeyBancScott Schoenhaus | $9 | 100.9% upside | |
| 2024-03-25 | Wells FargoStan Berenshteyn | $10 | 123.2% upside | |
| 2023-11-13 | Goldman SachsEric Sheridan | $3 |  33% downside | |
| 2022-12-01 | Citigroup | $7 | 56.2% upside | |
| 2022-08-09 | BarclaysSteve Valiquette | $13 | 190.2% upside | |
| 2022-06-07 | Robert W. BairdVikram Kesavabhotla | $7 | 56.2% upside | |
| 2022-05-12 | Wells FargoStan Berenshteyn | $9 | 100.9% upside | |
| 2022-03-01 | Cowen & Co.Charles Rhyee | $22 | 391.1% upside | |
| 2022-03-01 | J.P. MorganDoug Anmuth | $20 | 346.4% upside | |
| 2022-03-01 | Goldman SachsEric Sheridan | $30 | 569.6% upside | |
| 2022-03-01 | Deutsche BankGeorge Hill | $20 | 346.4% upside | |
| 2022-03-01 | Bank of America SecuritiesJustin Post | $28 | 525% upside | |
| 2021-12-21 | StephensScott Schoenhaus | $45 | 904.5% upside | |
| 2021-05-14 | CitigroupNicholas Jones CFA | $53 | 1083% upside | |